Land: Australia
Språk: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Immunoglobulin G - human; Immunoglobulin - hepatitis B; Hepatitis B Immunoglobulin
Hepatitis B Immunoglobulin-VF_AU_CMI_7.00 Page 1 of 3 Consumer Medicine Information HEPATITIS B IMMUNOGLOBULIN-VF HUMAN HEPATITIS B IMMUNOGLOBULIN, SOLUTION FOR INTRAMUSCULAR INJECTION 100 IU AUST R 61213 400 IU AUST R 61214 WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Hepatitis B Immunoglobulin-VF. It does not contain complete information about Hepatitis B Immunoglobulin-VF. It does not take the place of talking to your doctor. If you have any concerns about using this product, ask your doctor. Follow your doctor's advice even if it is different from what this leaflet says. Please read this leaflet carefully and keep it for future reference. However, the information in this leaflet is subject to change. Please check with your doctor whether there is any new information about this product that you should know since you were last treated with this product. WHAT HEPATITIS B IMMUNOGLOBULIN-VF IS USED FOR Hepatitis B Immunoglobulin-VF is prepared from blood obtained from voluntary donors. Hepatitis B Immunoglobulin-VF contains protein substances called antibodies which can prevent infection from developing in a person who has been exposed to the hepatitis B virus. Hepatitis B Immunoglobulin-VF is used to prevent hepatitis B infection in a person who comes into contact with blood or other material suspected of being infected with hepatitis B, for example, by accidental needle stick injury or sexual exposure. It is also given to babies born to mothers with hepatitis B infection. Ask your doctor if you have any questions about why Hepatitis B Immunoglobulin-VF has been prescribed for you. Your doctor w read_full_document
Hepatitis B Immunoglobulin-VF_AU_PI_7.00 Page 1 of 5 Product Information HEPATITIS B IMMUNOGLOBULIN-VF AUSTRALIA NAME OF THE MEDICINE Human Hepatitis B Immunoglobulin, solution for intramuscular injection DESCRIPTION Hepatitis B Immunoglobulin-VF is a sterile, preservative-free solution containing 160 mg/mL human plasma proteins and 22.5 mg/mL glycine. The solution has a pH of 6.6. At least 98% of the protein is immunoglobulins (mainly IgG), with a hepatitis B antibody titre of not less than 100 IU/mL. Hepatitis B Immunoglobulin-VF is manufactured from plasma donated by Australia’s voluntary and non-remunerated donors. Donations are selected on the basis that they contain high levels of antibody to hepatitis B surface antigen (HBsAg). Immunoglobulins for intramuscular injection, prepared by this process from plasma screened by current methods, have not been implicated in the transmission of viral infectious diseases including human immunodeficiency virus (HIV). Studies using plasma spiked with HIV have shown that the Cohn cold-ethanol fractionation process produces a very large reduction in virus titre with undetectable levels in the immunoglobulin fraction. Epidemiological studies have not recognised any cluster of AIDS patients or HIV seroconversion in immunoglobulin recipients. The manufacturing process for Hepatitis B Immunoglobulin contains specific steps to reduce the possibility of viral transmission including pasteurisation for viral inactivation and nanofiltration for virus removal. PHARMACOLOGY Hepatitis B Immunoglobulin-VF contains specific neutralising antibodies (mainly IgG) against HBsAg. Pharmacological data is pre read_full_document